NTRA
- Natera, Inc.
()
Overview
Company Summary
Natera, Inc. is a biotechnology company that specializes in molecular- and genetic-based diagnostic tests. The company focuses on developing and commercializing innovative products to help diagnose and monitor a range of conditions, including reproductive health, organ transplantation, and cancer. Natera's core technology, known as cell-free DNA analysis, utilizes advanced techniques in sequencing and bioinformatics to analyze fragments of DNA that circulate freely in a person's bloodstream.
In the field of reproductive health, Natera offers non-invasive prenatal testing (NIPT) solutions that provide valuable information about a baby's genetic health during pregnancy. These tests can screen for a variety of genetic conditions, including Down syndrome, trisomy 18, and trisomy 13, without the need for invasive procedures such as amniocentesis. Natera's tests are widely used by healthcare providers to aid in prenatal care decision-making.
Natera also provides genetic testing services for patients undergoing organ transplantation. The company's proprietary technology allows for the monitoring of transplant recipients by detecting and measuring levels of donor-derived cell-free DNA (dd-cfDNA) in their blood. This can help identify potential organ rejection earlier than traditional methods, leading to better management and outcomes for transplant patients.
Furthermore, Natera is actively involved in cancer diagnostics, offering liquid biopsy tests that detect genetic mutations associated with various types of cancer. These tests allow physicians to monitor tumor progression, treatment response, and minimal residual disease in cancer patients by detecting and analyzing tumor-derived genetic material from a simple blood draw. This technology enables personalized cancer treatment approaches and facilitates precision medicine.
Overall, Natera, Inc. leverages its expertise in molecular- and genetic-based diagnostics to develop and commercialize advanced tests that provide actionable information for patients and healthcare providers in the areas of reproductive health, organ transplantation, and cancer.